Fig. 3From: Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis)Multiple comparison of neutrophil count by G-CSF type. a duration of neutropenia, b incidence of Grade 4 neutropenia, c neutrophil nadir, d days of onset of the neutrophil nadir. G-CSF granulocyte colony-stimulating factorBack to article page